• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管重建术对患有下肢缺血的九旬老人的益处因高死亡率而受限。

The benefit of revascularization in nonagenarians with lower limb ischemia is limited by high mortality.

作者信息

Saarinen E, Vuorisalo S, Kauhanen P, Albäck A, Venermo M

机构信息

Department of Vascular Surgery, University of Helsinki and Helsinki University Hospital, Finland.

Department of Vascular Surgery, University of Helsinki and Helsinki University Hospital, Finland.

出版信息

Eur J Vasc Endovasc Surg. 2015 Apr;49(4):420-5. doi: 10.1016/j.ejvs.2014.12.027. Epub 2015 Feb 16.

DOI:10.1016/j.ejvs.2014.12.027
PMID:25698087
Abstract

OBJECTIVE/BACKGROUND: Owing to the increased life expectancy of the population the number of very old patients referred to vascular surgical units has increased. Advanced age is a well known risk factor in patients undergoing surgical interventions for lower limb ischemia. However, amputation performed on an elderly person living independently will lead to permanent institutional care. The aim of this study was to evaluate the outcome of patients aged 90 years and older with lower limb ischemia undergoing surgical or endovascular revascularization.

METHODS

Two hundred and thirty-three nonagenarians with either chronic critical limb ischemia (CLI) or acute limb ischemia (ALI) who underwent revascularization at the authors' institution between 2002 and 2013 were included in this retrospective study. Risk factors were evaluated and survival, limb salvage, and amputation free survival (AFS) assessed.

RESULTS

The median age of the study population was 92 years (range 90-100 years). The majority (81.1%) of the patients were female. One in four (24.5%) patients had diabetes, and the incidence of coronary artery disease was 79.8%. Seventy-three percent of the patients had CLI and 27% of had ALI. Seventy percent of the patients underwent surgical revascularization and 30% were treated endovascularly. The majority (72.5%) of the patients maintained their independent living status; 27.5% ended up in institutional care post-operatively. Similarly, the majority (82.0%) of the patients maintained their walking ability, while 18% were not able to ambulate independently after revascularization. One year survival, limb salvage, and AFS rates were 50.9% versus 48.6% (p = .505), 85.1% versus 87.0% (p = .259), and 45.7% versus 44.4% (p = .309) in the surgical versus endovascular group, respectively. Dementia was an independent risk factor of poor AFS (odds ratio: 1.56; 95% confidence interval: 1.077-2.272; p = .019).

CONCLUSION

Good limb salvage can be achieved by both surgical and endovascular revascularization, and independent living can be maintained in the majority of the patients. However, the benefit of revascularization is limited owing to high mortality, especially in patients with dementia.

摘要

目的/背景:由于人口预期寿命的增加,转诊至血管外科的高龄患者数量有所上升。高龄是下肢缺血患者接受外科手术干预时一个众所周知的风险因素。然而,对独立生活的老年人进行截肢会导致其永久性入住机构护理。本研究的目的是评估90岁及以上下肢缺血患者接受外科或血管腔内血运重建的结果。

方法

本回顾性研究纳入了2002年至2013年间在作者所在机构接受血运重建的233例患有慢性严重肢体缺血(CLI)或急性肢体缺血(ALI)的九旬老人。评估了风险因素,并对生存、肢体挽救和无截肢生存(AFS)情况进行了评估。

结果

研究人群的中位年龄为92岁(范围90 - 100岁)。大多数患者(81.1%)为女性。四分之一(24.5%)的患者患有糖尿病,冠状动脉疾病的发生率为79.8%。73%的患者患有CLI,27%患有ALI。70%的患者接受了外科血运重建,30%接受了血管腔内治疗。大多数患者(72.5%)维持了独立生活状态;27.5%在术后最终入住机构护理。同样,大多数患者(82.0%)维持了行走能力,而18%在血运重建后无法独立行走。外科组与血管腔内组的1年生存率、肢体挽救率和AFS率分别为50.9%对48.6%(p = 0.505)、85.1%对87.0%(p = 0.259)和45.7%对44.4%(p = 0.309)。痴呆是AFS不良的独立危险因素(比值比:1.56;95%置信区间:1.077 - 2.272;p = 0.019)。

结论

外科和血管腔内血运重建均可实现良好的肢体挽救,且大多数患者可维持独立生活。然而,由于高死亡率,尤其是痴呆患者,血运重建的获益有限。

相似文献

1
The benefit of revascularization in nonagenarians with lower limb ischemia is limited by high mortality.血管重建术对患有下肢缺血的九旬老人的益处因高死亡率而受限。
Eur J Vasc Endovasc Surg. 2015 Apr;49(4):420-5. doi: 10.1016/j.ejvs.2014.12.027. Epub 2015 Feb 16.
2
Surgery for acute lower limb ischemia in the elderly population: results of a comparative study.老年人群急性下肢缺血的手术治疗:一项对比研究的结果
Ann Vasc Surg. 2011 Oct;25(7):947-53. doi: 10.1016/j.avsg.2010.12.036. Epub 2011 May 28.
3
Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia.胰岛素的使用与慢性肢体缺血的糖尿病患者肢体保存和生存不良有关。
J Vasc Surg. 2010 May;51(5):1178-89; discussion 1188-9. doi: 10.1016/j.jvs.2009.11.077. Epub 2010 Mar 20.
4
Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.对于严重肢体缺血患者,腹股沟下单节段大隐静脉旁路移植术的效果优于其他自体静脉旁路移植术,尤其是在手术风险较高的患者中。
Ann Vasc Surg. 2012 Apr;26(3):396-403. doi: 10.1016/j.avsg.2011.08.013. Epub 2012 Jan 27.
5
Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions.严重肢体缺血血管重建术后功能结局的决定因素:对1000例连续血管介入治疗的分析
J Vasc Surg. 2006 Oct;44(4):747-55; discussion 755-6. doi: 10.1016/j.jvs.2006.06.015. Epub 2006 Aug 22.
6
Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, 1996-1999, with follow-up through 2004.1996 - 1999年加利福尼亚州医院下肢搭桥手术后的围手术期结果及无截肢生存率,随访至2004年。
J Vasc Surg. 2009 Oct;50(4):776-783.e1. doi: 10.1016/j.jvs.2009.05.050. Epub 2009 Jul 12.
7
Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure.对于严重肢体缺血,下肢自体静脉搭桥术不会受到先前血管内介入治疗的不利影响。
J Vasc Surg. 2014 Jul;60(1):129-35. doi: 10.1016/j.jvs.2014.01.013. Epub 2014 Mar 7.
8
Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia.西洛他唑对伴有严重肢体缺血的下肢动脉疾病腔内治疗后的影响。
J Vasc Surg. 2011 Dec;54(6):1659-67. doi: 10.1016/j.jvs.2011.06.024. Epub 2011 Aug 27.
9
Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.他汀类药物治疗对严重肢体缺血患者膝下孤立性疾病血管内治疗后的疗效。
Cardiovasc Interv Ther. 2013 Oct;28(4):374-82. doi: 10.1007/s12928-013-0188-6. Epub 2013 Jun 12.
10
Functional status as a prognostic factor for primary revascularization for critical limb ischemia.功能状态作为临界肢体缺血患者初次血运重建的预后因素。
J Vasc Surg. 2010 Feb;51(2):360-71.e1. doi: 10.1016/j.jvs.2009.08.051.

引用本文的文献

1
Revascularization in Nonagenarians with Chronic Limb-Threatening Ischemia Can Be Effective.对患有慢性肢体威胁性缺血的九旬老人进行血管重建术可能是有效的。
Cardiovasc Intervent Radiol. 2025 Jun 9. doi: 10.1007/s00270-025-04065-z.
2
Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.亚太共识声明:外周动脉疾病管理:来自亚太动脉粥样硬化和血管疾病学会外周动脉疾病共识声明项目委员会的报告。
J Atheroscler Thromb. 2020 Aug 1;27(8):809-907. doi: 10.5551/jat.53660. Epub 2020 Jul 4.
3
Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis.
早期血栓抽吸术及替罗非班在膝部及膝下动脉血栓形成中的应用
Med Sci Monit. 2017 Apr 30;23:2072-2077. doi: 10.12659/msm.901395.
4
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 AHA/ACC 指南:下肢外周动脉疾病患者管理——美国心脏病学会/美国心脏协会实践指南工作组的报告。
Circulation. 2017 Mar 21;135(12):e726-e779. doi: 10.1161/CIR.0000000000000471. Epub 2016 Nov 13.
5
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 年美国心脏协会/美国心脏病学会下肢外周动脉疾病管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2017 Mar 21;135(12):e686-e725. doi: 10.1161/CIR.0000000000000470. Epub 2016 Nov 13.
6
Emergency surgery in the elderly: challenges and solutions.老年患者的急诊手术:挑战与解决方案
Open Access Emerg Med. 2015 Sep 8;7:55-68. doi: 10.2147/OAEM.S68324. eCollection 2015.